Cita APA

C, F., D, D., K, C., HP, G., M, C., DP, T., . . . J, S. (2014). Pharmacokinetics and 48-week Safety and Antiviral Activity of Fosamprenavir-containing Regimens in HIV-infected 2-to 18-year-old Children.

Citación estilo Chicago

C, Fortuny, et al. Pharmacokinetics and 48-week Safety and Antiviral Activity of Fosamprenavir-containing Regimens in HIV-infected 2-to 18-year-old Children. 2014.

Cita MLA

C, Fortuny, et al. Pharmacokinetics and 48-week Safety and Antiviral Activity of Fosamprenavir-containing Regimens in HIV-infected 2-to 18-year-old Children. 2014.